Patent ID: 11903992
Assignee: CELLIX BIO PRIVATE LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 8:
9. The composition of claim 1, wherein the composition comprises
lidocaine or a salt or a hydrate or a solvate thereof in an amount ranging from 0.25% w/v to 10% w/v;
L-Carnosine or a salt or a hydrate or a solvate thereof in an amount ranging from 0.25% w/v to 5% w/v;
dexpanthenol or a salt or a hydrate or a solvate thereof in an amount ranging from 0.5% w/v to 25% w/v;
a polyhydric alcohol in an amount ranging from 5% w/v to 30% w/v;
an anti-oxidant in an amount ranging from 0.01% w/v to 3% w/v;
a buffer in an amount ranging from 0.02% w/v to 5% w/v;
a surfactant in an amount ranging from 1% w/v to 30% w/v;
a sweetener in an amount ranging from 0.5% w/v to 25% w/v;
a preservative in an amount ranging from 0.01% w/v to 5% w/v; and
water in an amount ranging from 35% w/v to 90% w/v.